Prurisol: Efficacy seems to be dose-related in Pha
Post# of 72430
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
In the ITT population where >= 2-point improvement in IGA was observed at week 12, 25% was in the 200 mg arm, 10.7% was in the 100 mg arm, 10.3% was in the 50 mg arm.
In the PP population where >= 2-point improvement in IGA was observed at week 12, 35% was in the 200 mg arm, 13% was in the 100 mg arm, 15% was in the 50 mg arm.
Dosage in Phase 2b will increase to 300 mg and 400 mg, so efficacy should improve.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)